ANTX AN2 THERAPEUTICS INC
FollowCOM (common), issuer CIK 1880438
Filings received so far for Q3 2026: 1 13F filer report a position in ANTX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Marks Gilbert Lynndirector | 2026-10-12 | +2,283 A | $0 | Form 4 |
| Martin Patricia A.director | 2026-10-12 | +389 A | $0 | Form 4 |
| Aziz Kabeerdirector | 2026-10-12 | +2,465 A | $0 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GAMMA Investing LLC | 191 | $1.02K | <0.01% | new | 13F-HRTimeline |
Events
Marks Gilbert Lynn acquired 2,283 ANTX shares on 2026-10-12, Form 4 filed 2026-10-13. 0001193125-26-420643
Accepted , ingestedMartin Patricia A. acquired 389 ANTX shares on 2026-10-12, Form 4 filed 2026-10-13. 0001193125-26-420641
Accepted , ingestedAziz Kabeer acquired 2,465 ANTX shares on 2026-10-12, Form 4 filed 2026-10-13. 0001193125-26-420639
Accepted , ingested